| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 6.82e-09 | 5 | 123 | 4 | GO:0035731 | |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 4.73e-08 | 7 | 123 | 4 | GO:0004769 | |
| GeneOntologyMolecularFunction | glutathione peroxidase activity | 7.17e-07 | 28 | 123 | 5 | GO:0004602 | |
| GeneOntologyMolecularFunction | glutathione binding | 3.92e-06 | 18 | 123 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | piRNA binding | 4.50e-06 | 6 | 123 | 3 | GO:0034584 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing C=C bonds | 4.95e-06 | 19 | 123 | 4 | GO:0016863 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 6.15e-06 | 20 | 123 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 2.89e-05 | 29 | 123 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | peroxidase activity | 5.02e-05 | 65 | 123 | 5 | GO:0004601 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on peroxide as acceptor | 5.82e-05 | 67 | 123 | 5 | GO:0016684 | |
| GeneOntologyMolecularFunction | antioxidant activity | 3.35e-04 | 97 | 123 | 5 | GO:0016209 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 4.21e-04 | 57 | 123 | 4 | GO:0016860 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 5.26e-04 | 107 | 123 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 5.80e-04 | 62 | 123 | 4 | GO:0061980 | |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 6.55e-04 | 64 | 123 | 4 | GO:0016765 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.94e-04 | 65 | 123 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 7.75e-04 | 7 | 123 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | fatty acid binding | 8.70e-04 | 69 | 123 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 9.54e-04 | 122 | 123 | 5 | GO:0072341 | |
| GeneOntologyMolecularFunction | protein dimerization activity | RAN KRT10 S100A16 SSBP1 SIM1 CLPX GSTA1 GSTA2 GSTA3 H2BC1 NOD1 TENM4 ABCB9 GSTA5 FUT9 KYAT3 DIAPH3 | 1.15e-03 | 1205 | 123 | 17 | GO:0046983 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.44e-03 | 79 | 123 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.52e-03 | 37 | 123 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.55e-03 | 136 | 123 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | metal cluster binding | 1.73e-03 | 83 | 123 | 4 | GO:0051540 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.89e-03 | 85 | 123 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 2.39e-03 | 12 | 123 | 2 | GO:0017154 | |
| Domain | GST_alpha | 9.21e-09 | 5 | 124 | 4 | IPR003080 | |
| Domain | GST_N | 1.23e-05 | 22 | 124 | 4 | PF02798 | |
| Domain | GST_NTER | 1.23e-05 | 22 | 124 | 4 | PS50404 | |
| Domain | PIWI | 1.56e-05 | 8 | 124 | 3 | PS50822 | |
| Domain | Piwi | 1.56e-05 | 8 | 124 | 3 | SM00950 | |
| Domain | Piwi | 1.56e-05 | 8 | 124 | 3 | PF02171 | |
| Domain | Piwi | 1.56e-05 | 8 | 124 | 3 | IPR003165 | |
| Domain | PAZ | 2.33e-05 | 9 | 124 | 3 | PS50821 | |
| Domain | PAZ | 2.33e-05 | 9 | 124 | 3 | SM00949 | |
| Domain | PAZ | 2.33e-05 | 9 | 124 | 3 | PF02170 | |
| Domain | PAZ_dom | 2.33e-05 | 9 | 124 | 3 | IPR003100 | |
| Domain | GST_C | 2.47e-05 | 26 | 124 | 4 | IPR004046 | |
| Domain | GST_C | 2.47e-05 | 26 | 124 | 4 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 2.89e-05 | 27 | 124 | 4 | IPR004045 | |
| Domain | GST_C_3 | 3.31e-05 | 10 | 124 | 3 | PF14497 | |
| Domain | GST_CTER | 7.36e-05 | 34 | 124 | 4 | PS50405 | |
| Domain | Glutathione-S-Trfase_C-like | 1.27e-04 | 39 | 124 | 4 | IPR010987 | |
| Domain | - | 1.27e-04 | 39 | 124 | 4 | 1.20.1050.10 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NFE2L2_IN_RESPONSE_TO_PHYTOCHEMICALS | 3.63e-06 | 17 | 91 | 4 | MM15891 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 5.85e-06 | 19 | 91 | 4 | M47809 | |
| Pathway | REACTOME_HEME_DEGRADATION | 7.27e-06 | 20 | 91 | 4 | MM14721 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 1.09e-05 | 22 | 91 | 4 | MM1449 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.09e-05 | 22 | 91 | 4 | MM15888 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 1.31e-05 | 23 | 91 | 4 | M47806 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.56e-05 | 24 | 91 | 4 | M11190 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 1.56e-05 | 24 | 91 | 4 | M47487 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 2.55e-05 | 27 | 91 | 4 | MM15908 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 2.55e-05 | 27 | 91 | 4 | MM15693 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 5.09e-05 | 32 | 91 | 4 | MM14719 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 8.17e-05 | 36 | 91 | 4 | M1443 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 9.00e-05 | 14 | 91 | 3 | MM15011 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.01e-04 | 38 | 91 | 4 | MM14600 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 1.37e-04 | 16 | 91 | 3 | M925 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 2.98e-04 | 50 | 91 | 4 | M1840 | |
| Pubmed | 1.49e-10 | 10 | 127 | 5 | 15870285 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 12557262 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 1728405 | ||
| Pubmed | Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice. | 1.70e-10 | 4 | 127 | 4 | 24964013 | |
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 2049074 | ||
| Pubmed | Glutathione S-transferase A1 - a sensitive marker of alcoholic injury on primary hepatocytes. | 1.70e-10 | 4 | 127 | 4 | 27198676 | |
| Pubmed | Mouse glutathione S-transferase Ya subunit: gene structure and sequence. | 1.70e-10 | 4 | 127 | 4 | 3652905 | |
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 9606968 | ||
| Pubmed | 5'-flanking sequence of mouse glutathione S-transferase Ya gene. | 1.70e-10 | 4 | 127 | 4 | 2893339 | |
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 1526290 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 16786188 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 6330685 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 19029078 | ||
| Pubmed | 8.45e-10 | 5 | 127 | 4 | 9268051 | ||
| Pubmed | 8.45e-10 | 5 | 127 | 4 | 12020353 | ||
| Pubmed | Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. | 8.45e-10 | 5 | 127 | 4 | 3417659 | |
| Pubmed | Expression pattern of GSTP1 and GSTA1 in the pathogenesis of asthma. | 8.45e-10 | 5 | 127 | 4 | 23647087 | |
| Pubmed | 8.45e-10 | 5 | 127 | 4 | 11851347 | ||
| Pubmed | 8.45e-10 | 5 | 127 | 4 | 16243960 | ||
| Pubmed | Zonal expression and activity of glutathione S-transferase enzymes in the mouse olfactory mucosa. | 2.53e-09 | 6 | 127 | 4 | 14672804 | |
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 1427837 | ||
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 8584275 | ||
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 7894162 | ||
| Pubmed | 1.17e-08 | 8 | 127 | 4 | 16284450 | ||
| Pubmed | 1.17e-08 | 8 | 127 | 4 | 7774561 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RAN FLNC POGLUT3 SERBP1 CTSC RPS16 CP ABCF2 ATP5MF RPSA SSBP1 NDUFA4 CLPX ITGAV NRP2 NCOR2 IGF2R PTPRC SF3A3 SCFD1 DNAH6 TRAPPC9 | 1.42e-08 | 1451 | 127 | 22 | 30550785 |
| Pubmed | Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice. | 2.11e-08 | 9 | 127 | 4 | 1685137 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 UBR1 RAN FLNC IARS1 RPS16 ABCF2 RPSA SSBP1 PHF8 CLPX MIDEAS ERLIN1 NMD3 RLF NCOR2 ASPM SF3A3 DDX60L SCFD1 RPA1 | 2.12e-08 | 1353 | 127 | 21 | 29467282 |
| Pubmed | 3.50e-08 | 10 | 127 | 4 | 1981995 | ||
| Pubmed | Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. | 5.49e-08 | 11 | 127 | 4 | 21554947 | |
| Pubmed | 5.49e-08 | 11 | 127 | 4 | 15100242 | ||
| Pubmed | MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues. | 8.20e-08 | 12 | 127 | 4 | 8297798 | |
| Pubmed | 1.18e-07 | 13 | 127 | 4 | 9441664 | ||
| Pubmed | 1.18e-07 | 13 | 127 | 4 | 36421460 | ||
| Pubmed | 1.18e-07 | 13 | 127 | 4 | 2572508 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 8307579 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 28025795 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 20940137 | ||
| Pubmed | 2.98e-07 | 16 | 127 | 4 | 8649810 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 23650189 | ||
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 9.96e-07 | 281 | 127 | 9 | 30455355 | |
| Pubmed | 1.49e-06 | 295 | 127 | 9 | 26209609 | ||
| Pubmed | Resveratrol improves health and survival of mice on a high-calorie diet. | 2.38e-06 | 26 | 127 | 4 | 17086191 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DDX47 UBR1 RAN FLNC SPAG1 IPO8 S100A16 IARS1 CP RPSA SSBP1 CLPX DNAJB14 ERLIN1 NCOR2 IGF2R SF3A3 SCFD1 | 2.53e-06 | 1367 | 127 | 18 | 32687490 |
| Pubmed | Orphan G protein-coupled receptor GPR116 regulates pulmonary surfactant pool size. | 2.63e-06 | 8 | 127 | 3 | 23590306 | |
| Pubmed | RAN FLNC KRT10 SERBP1 IARS1 RPS16 ABCF2 ATP5MF RPSA SSBP1 PHF8 CLPX ERLIN1 | 2.72e-06 | 725 | 127 | 13 | 27025967 | |
| Pubmed | DDX47 RAN SERBP1 IPO8 ARID4B RPS16 ABCF2 RPSA SSBP1 NDUFA4 PHF8 CLPX RLF ASPM CTNNA2 | 2.79e-06 | 971 | 127 | 15 | 33306668 | |
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 3.93e-06 | 9 | 127 | 3 | 12906857 | |
| Pubmed | 4.32e-06 | 30 | 127 | 4 | 20200426 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 DDX47 RAN SERBP1 IPO8 IARS1 RPS16 ABCF2 RPSA SSBP1 NDUFA4 CLPX NMD3 IGF2R SF3A3 COPS4 SCFD1 RPA1 | 4.49e-06 | 1425 | 127 | 18 | 30948266 |
| Pubmed | Sim2 mutants have developmental defects not overlapping with those of Sim1 mutants. | 5.60e-06 | 10 | 127 | 3 | 12024028 | |
| Pubmed | DDX47 RAN KRT10 SERBP1 IARS1 CTSC KLC2 RPS16 ABCF2 RPSA DNAJB14 NMD3 NCOR2 IGF2R PTPRC STAMBPL1 | 5.86e-06 | 1168 | 127 | 16 | 19946888 | |
| Pubmed | DDX47 RAN FLNC KRT10 IARS1 RPS16 RPSA SSBP1 ITGAV IGF2R SF3A3 RPA1 | 1.16e-05 | 707 | 127 | 12 | 19738201 | |
| Pubmed | Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis. | 1.32e-05 | 2 | 127 | 2 | 27893851 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 38310670 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11668220 | ||
| Pubmed | Human liver glutathione S-transferases: complete primary sequence of an Ha subunit cDNA. | 1.32e-05 | 2 | 127 | 2 | 3800996 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 9922219 | ||
| Pubmed | Maternal surfactant protein A influences the immunoprotective properties of milk in a murine model. | 1.32e-05 | 2 | 127 | 2 | 24858142 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 24954098 | ||
| Pubmed | Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients. | 1.32e-05 | 2 | 127 | 2 | 22748119 | |
| Pubmed | Nucleotide sequence of the human liver glutathione S-transferase subunit 1 cDNA. | 1.32e-05 | 2 | 127 | 2 | 3678589 | |
| Pubmed | Surfactant protein A modulates neuroinflammation in adult mice upon pulmonary infection. | 1.32e-05 | 2 | 127 | 2 | 38964703 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 34917085 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22219327 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15890661 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15385504 | ||
| Pubmed | A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation. | 1.32e-05 | 2 | 127 | 2 | 23475791 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23038062 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 29394894 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 17307210 | ||
| Pubmed | The basic glutathione S-transferases from human livers are products of separate genes. | 1.32e-05 | 2 | 127 | 2 | 3036131 | |
| Pubmed | Surfactant protein A modulates induction of regulatory T cells via TGF-β. | 1.32e-05 | 2 | 127 | 2 | 22474025 | |
| Pubmed | Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice. | 1.32e-05 | 2 | 127 | 2 | 38553537 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 28827731 | ||
| Pubmed | Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum. | 1.32e-05 | 2 | 127 | 2 | 33510368 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 21163259 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19392648 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15128049 | ||
| Pubmed | Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. | 1.32e-05 | 2 | 127 | 2 | 11342662 | |
| Pubmed | Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. | 1.32e-05 | 2 | 127 | 2 | 9126996 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 2050021 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11692074 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 19335775 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 12922979 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 20083122 | ||
| Pubmed | Differences in the alveolar macrophage toponome in humanized SP-A1 and SP-A2 transgenic mice. | 1.32e-05 | 2 | 127 | 2 | 33141765 | |
| Pubmed | MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. | 1.32e-05 | 2 | 127 | 2 | 17395546 | |
| Pubmed | Innate immunity of surfactant protein A in experimental otitis media. | 1.32e-05 | 2 | 127 | 2 | 31378117 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11237812 | ||
| Pubmed | MIWI2 and MILI Have Differential Effects on piRNA Biogenesis and DNA Methylation. | 1.32e-05 | 2 | 127 | 2 | 26279574 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 27916681 | ||
| Pubmed | Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. | 1.32e-05 | 2 | 127 | 2 | 12959932 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15044702 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 1986781 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 12740217 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 18083768 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 35322074 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 2604726 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 9700084 | ||
| Interaction | GSTA2 interactions | 2.61e-07 | 10 | 122 | 4 | int:GSTA2 | |
| Interaction | GSTA3 interactions | 2.15e-06 | 5 | 122 | 3 | int:GSTA3 | |
| Interaction | FNDC5 interactions | RAN FLNC POGLUT3 SERBP1 SAMD9 CTSC RPS16 CP ABCF2 ATP5MF RPSA SSBP1 NDUFA4 CLPX ITGAV NRP2 NCOR2 IGF2R PTPRC SF3A3 ENDOU SCFD1 DNAH6 TRAPPC9 | 6.86e-06 | 1470 | 122 | 24 | int:FNDC5 |
| Interaction | GSTA1 interactions | 8.59e-06 | 22 | 122 | 4 | int:GSTA1 | |
| Interaction | GSTA5 interactions | 1.77e-05 | 9 | 122 | 3 | int:GSTA5 | |
| Interaction | CFD interactions | RAN FLNC POGLUT3 SERBP1 CTSC RPS16 CP ABCF2 ATP5MF RPSA SSBP1 NDUFA4 CLPX ITGAV NRP2 NCOR2 IGF2R PTPRC SF3A3 SCFD1 DNAH6 TRAPPC9 | 2.04e-05 | 1360 | 122 | 22 | int:CFD |
| Interaction | NCAPH interactions | 2.22e-05 | 315 | 122 | 10 | int:NCAPH | |
| Interaction | H2BC5 interactions | 3.38e-05 | 331 | 122 | 10 | int:H2BC5 | |
| Interaction | NXPH2 interactions | 4.57e-05 | 33 | 122 | 4 | int:NXPH2 | |
| Interaction | GSTA4 interactions | 4.58e-05 | 12 | 122 | 3 | int:GSTA4 | |
| Interaction | CDK9 interactions | RAN KRT10 SERBP1 IARS1 RPS16 ABCF2 RPSA NDUFA4 DOCK5 H2BC1 UBE2H SF3A3 ELK1 RPA1 | 6.96e-05 | 685 | 122 | 14 | int:CDK9 |
| Interaction | MINDY4 interactions | 8.09e-05 | 73 | 122 | 5 | int:MINDY4 | |
| Cytoband | 6p12.1 | 1.06e-04 | 33 | 127 | 3 | 6p12.1 | |
| GeneFamily | Glutathione S-transferases | 5.09e-06 | 25 | 84 | 4 | 567 | |
| GeneFamily | Argonaute/PIWI family | 5.33e-06 | 8 | 84 | 3 | 408 | |
| GeneFamily | Collectins | 9.37e-04 | 10 | 84 | 2 | 491 | |
| GeneFamily | Trafficking protein particle complex | 1.87e-03 | 14 | 84 | 2 | 772 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 6.97e-08 | 44 | 127 | 6 | MM485 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_PODOCYTE_AGEING | 1.42e-06 | 222 | 127 | 9 | MM3733 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN | 5.18e-06 | 24 | 127 | 4 | MM708 | |
| Coexpression | WENG_POR_TARGETS_GLOBAL_UP | 5.18e-06 | 24 | 127 | 4 | MM1190 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN | 5.94e-06 | 199 | 127 | 8 | M7953 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP | 6.16e-06 | 200 | 127 | 8 | M4884 | |
| Coexpression | WENG_POR_DOSAGE | 1.31e-05 | 30 | 127 | 4 | MM1199 | |
| Coexpression | GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN | 2.76e-05 | 179 | 127 | 7 | M8900 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN | 5.08e-05 | 197 | 127 | 7 | M4489 | |
| ToppCell | suprabasal_cell|World / shred by cell class for bronchial biopsy | 9.67e-08 | 196 | 127 | 8 | 3c1fa7ec1c7e02b45b2c5843d2c5b2063cd13be8 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-07 | 200 | 127 | 8 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-07 | 139 | 127 | 7 | da8874d441b8e69c94bad771635f378ddafb49fe | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-07 | 139 | 127 | 7 | 6396434c1cb209193ccdf15581ec2adacf941d85 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT1_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-07 | 141 | 127 | 7 | b46ee98ed84ccb2696dcce40412f2d2288c677f4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.16e-06 | 188 | 127 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 188 | 127 | 7 | eadcf90b526be8fe567267da83966c8802608030 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 189 | 127 | 7 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 189 | 127 | 7 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 189 | 127 | 7 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-06 | 192 | 127 | 7 | 2360824910cd471c8286ca369ba144d90d984602 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-06 | 193 | 127 | 7 | ac1073bf4d3868841226b850b058f1e27326a14e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-06 | 194 | 127 | 7 | fc40ab57be3a15c043e3414c2c678c1dc52207c8 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-06 | 194 | 127 | 7 | 50fa7c7940b113427c87fbdb9057fef8e1ce52c5 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 125 | 127 | 6 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 198 | 127 | 7 | 5d57acbe0d245f8bd217eeea07af060092898fbd | |
| ToppCell | proximal-Epithelial-Club|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-06 | 199 | 127 | 7 | 99d23c0373f1ae5267bb3e51c5c88c8f52559ae4 | |
| ToppCell | proximal-Epithelial-Club-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-06 | 199 | 127 | 7 | e8b3b003b581aa001c23440a03d80da9560129b3 | |
| ToppCell | proximal-3-Epithelial-Club|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-06 | 199 | 127 | 7 | 77dc850032746339557c844cfc1f93eb27210f22 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 127 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | distal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.76e-06 | 200 | 127 | 7 | 0a97080f694738bb882787cee21b91a4d5757b7a | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.76e-06 | 200 | 127 | 7 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.76e-06 | 200 | 127 | 7 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 131 | 127 | 6 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-new-cluster|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 134 | 127 | 6 | dd0144af4f78d3483f129f908aadb1d67002aa9f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-06 | 162 | 127 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.69e-06 | 164 | 127 | 6 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.69e-06 | 164 | 127 | 6 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.76e-06 | 171 | 127 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 103 | 127 | 5 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-05 | 179 | 127 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 105 | 127 | 5 | 9ed5482b445eacf16d5769f79438098b0e71123a | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 181 | 127 | 6 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-05 | 182 | 127 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-05 | 183 | 127 | 6 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 184 | 127 | 6 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 185 | 127 | 6 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 186 | 127 | 6 | 3dae539cce15fcf2b1b32e981d7febe94c03c600 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 186 | 127 | 6 | 2cbf1aaff87cd9fba01f814a119fe86e5af82290 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 187 | 127 | 6 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 188 | 127 | 6 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.67e-05 | 188 | 127 | 6 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.72e-05 | 189 | 127 | 6 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.72e-05 | 189 | 127 | 6 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 190 | 127 | 6 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 190 | 127 | 6 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-05 | 191 | 127 | 6 | e96184aee03175fd9f1da11fa2b89d95ba58b817 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 191 | 127 | 6 | edfd5eeff69b5de19c5df3d899e42acd7e015913 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.83e-05 | 191 | 127 | 6 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-05 | 191 | 127 | 6 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 191 | 127 | 6 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 191 | 127 | 6 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.83e-05 | 191 | 127 | 6 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 191 | 127 | 6 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 1.83e-05 | 191 | 127 | 6 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Endothelial-B|World / shred on cell class and cell subclass (v4) | 1.83e-05 | 191 | 127 | 6 | 8b7857dee69d0ba3e59e230c9fd372e14695299e | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-05 | 191 | 127 | 6 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 191 | 127 | 6 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.88e-05 | 192 | 127 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 193 | 127 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 193 | 127 | 6 | 1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 193 | 127 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 193 | 127 | 6 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | PND10-Endothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 193 | 127 | 6 | f3c743b340fc588bc8effd375b12e2c7cbfa49d2 | |
| ToppCell | PND14-Endothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 194 | 127 | 6 | cee89d4340738f09d07a159cd6aeee4300776988 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 194 | 127 | 6 | 6115c20ffe414378508f3879e67815b6062341a7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 194 | 127 | 6 | 32962060d80f3edffbe9f0ecad3000c3a9817865 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 194 | 127 | 6 | 6317e9cdf96eb020f84d50bf41f803db5c9c04a0 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 194 | 127 | 6 | 1b382508453c5b08fb617f626b230adf3b6cff99 | |
| ToppCell | PND28-Endothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 194 | 127 | 6 | b592c713204db7ae2f34a54f2d03d13834593c57 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-05 | 194 | 127 | 6 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 2.05e-05 | 195 | 127 | 6 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-05 | 195 | 127 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-05 | 196 | 127 | 6 | d9426eba69047166ffa8179f1654e011c1020328 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.11e-05 | 196 | 127 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-05 | 196 | 127 | 6 | 7e19919eafd6ddf547dd4e8aa532a050e182c5cc | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.11e-05 | 196 | 127 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.17e-05 | 197 | 127 | 6 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.17e-05 | 197 | 127 | 6 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.17e-05 | 197 | 127 | 6 | 1bf69db7e830315c8fa85e6e85b0cb94014e9169 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 2.24e-05 | 198 | 127 | 6 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-05 | 198 | 127 | 6 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | Goblet_2|World / shred by cell class for nasal brushing | 2.24e-05 | 198 | 127 | 6 | 6f9ffcef84dd2ab6084281f7b5169335e323304d | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-05 | 198 | 127 | 6 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 2.24e-05 | 198 | 127 | 6 | cd8a26de6c1cb9c42635146bb7220dd1b41ee97d | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.24e-05 | 198 | 127 | 6 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.24e-05 | 198 | 127 | 6 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.24e-05 | 198 | 127 | 6 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.30e-05 | 199 | 127 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.30e-05 | 199 | 127 | 6 | b44d74895846e2ac144438b73e0ca91e3949c16c | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.30e-05 | 199 | 127 | 6 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-05 | 199 | 127 | 6 | 4b374a5de82b4614d3d8a00202ea6cb8f1fd8104 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.30e-05 | 199 | 127 | 6 | 9e8231c9007d8d963805a4c99e0905538ceb9b60 | |
| ToppCell | tumor_Lung-Epithelial_cells|tumor_Lung / Location, Cell class and cell subclass | 2.30e-05 | 199 | 127 | 6 | 56b3f6c8b561d60780d91daf6b44a9dcf616e599 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.30e-05 | 199 | 127 | 6 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 127 | 6 | ccdde5d4bcc72f230a1dd2544ee7f4dfb98a5e80 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-05 | 199 | 127 | 6 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | COVID-19-lung-KRT8+_PATS/ADI/DATPs|lung / Disease (COVID-19 only), tissue and cell type | 2.37e-05 | 200 | 127 | 6 | 038831822b1b38af4eff022bc90a9ea0a3dea675 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.37e-05 | 200 | 127 | 6 | 6a76c8e3d937a9c54eb81cab23b8a898f9600de1 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Transitional_AT2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.37e-05 | 200 | 127 | 6 | dfa897ef5ce4744c77b6e5ee5a0d6d83229d1691 | |
| Drug | quercetin 3-arabinopyranoside | 1.33e-08 | 6 | 126 | 4 | ctd:C428865 | |
| Drug | benzotriazole | 6.59e-07 | 4 | 126 | 3 | ctd:C012771 | |
| Drug | Benzoxazoles | 1.64e-06 | 5 | 126 | 3 | ctd:D001583 | |
| Drug | Selenium Compounds | 1.64e-06 | 5 | 126 | 3 | ctd:D018036 | |
| Drug | Clch2cosg | 2.58e-06 | 18 | 126 | 4 | CID000163913 | |
| Drug | C14791 | 2.58e-06 | 18 | 126 | 4 | CID011954044 | |
| Drug | C14793 | 2.58e-06 | 18 | 126 | 4 | CID011954046 | |
| Drug | C14803 | 2.58e-06 | 18 | 126 | 4 | CID011954054 | |
| Drug | C14805 | 2.58e-06 | 18 | 126 | 4 | CID011954056 | |
| Drug | C14804 | 2.58e-06 | 18 | 126 | 4 | CID011954055 | |
| Drug | C14806 | 2.58e-06 | 18 | 126 | 4 | CID011954057 | |
| Drug | C14848 | 2.58e-06 | 18 | 126 | 4 | CID011954067 | |
| Drug | C14856 | 2.58e-06 | 18 | 126 | 4 | CID011954069 | |
| Drug | C14855 | 2.58e-06 | 18 | 126 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 2.58e-06 | 18 | 126 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 2.58e-06 | 18 | 126 | 4 | CID000188517 | |
| Drug | 2-allylphenol | 3.27e-06 | 6 | 126 | 3 | ctd:C099328 | |
| Drug | 1,2-dichloro-4-nitrobenzene | 3.27e-06 | 6 | 126 | 3 | ctd:C028328 | |
| Drug | 1-cyano-2-hydroxy-3-butene | 3.27e-06 | 6 | 126 | 3 | ctd:C055903 | |
| Drug | isomethyleugenol | 3.27e-06 | 6 | 126 | 3 | ctd:C031050 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 4.04e-06 | 20 | 126 | 4 | CID011954072 | |
| Drug | C14865 | 4.04e-06 | 20 | 126 | 4 | CID011954073 | |
| Drug | cafestol | 4.98e-06 | 21 | 126 | 4 | ctd:C053400 | |
| Drug | AA-GSH | 7.30e-06 | 23 | 126 | 4 | CID000083998 | |
| Drug | S-(formylmethyl)glutathione | 8.72e-06 | 24 | 126 | 4 | CID011954074 | |
| Drug | Selenocysteine | 9.08e-06 | 8 | 126 | 3 | ctd:D017279 | |
| Drug | kahweol palmitate | 9.08e-06 | 8 | 126 | 3 | ctd:C033997 | |
| Drug | Glucosinolates | 9.08e-06 | 8 | 126 | 3 | ctd:D005961 | |
| Drug | triethyllead | 9.08e-06 | 8 | 126 | 3 | ctd:C010360 | |
| Drug | dimethyl phthalate | FLT1 KRT10 CTSC SPIRE1 CP RPSA INO80 GSTA1 NCOR2 IGF2R ASPM ELK1 MMP1 RPA1 DNASE1L3 | 9.86e-06 | 714 | 126 | 15 | ctd:C024629 |
| Drug | AC1Q608X | 1.65e-05 | 28 | 126 | 4 | CID000128466 | |
| Drug | AC1L33DC | 1.65e-05 | 28 | 126 | 4 | CID000133757 | |
| Drug | 2-BHA | 1.91e-05 | 29 | 126 | 4 | CID000006932 | |
| Drug | imidazole | 1.93e-05 | 10 | 126 | 3 | ctd:C029899 | |
| Drug | aflatoxin B1-2,3-oxide | 1.93e-05 | 10 | 126 | 3 | ctd:C006426 | |
| Drug | Triazoles | 1.93e-05 | 10 | 126 | 3 | ctd:D014230 | |
| Drug | angelica lactone | 1.93e-05 | 10 | 126 | 3 | ctd:C019257 | |
| Drug | Dcvg | 2.51e-05 | 31 | 126 | 4 | CID006437359 | |
| Drug | o-dinitrobenzene | 2.51e-05 | 31 | 126 | 4 | CID000010707 | |
| Drug | 4-propylphenol | 2.64e-05 | 11 | 126 | 3 | ctd:C099327 | |
| Drug | 5-androstene-3,17-dione | 3.04e-05 | 2 | 126 | 2 | ctd:C003528 | |
| Drug | iproplatin | 3.04e-05 | 2 | 126 | 2 | ctd:C023359 | |
| Drug | Ibuprofen | RAN IARS1 ANXA3 CTSC KLC2 STPG2 GSTA1 IGF2R ABCB9 CTNNA2 MMP1 | 3.23e-05 | 437 | 126 | 11 | ctd:D007052 |
| Drug | m-toluidine | 3.65e-05 | 34 | 126 | 4 | CID000007934 | |
| Drug | Lyndiol | 3.65e-05 | 34 | 126 | 4 | CID000082149 | |
| Drug | diepoxybutane | 3.97e-05 | 113 | 126 | 6 | CID000011254 | |
| Drug | zinc sulfate | 4.06e-05 | 69 | 126 | 5 | CID000024424 | |
| Drug | dimethoxystrychnine | 4.10e-05 | 35 | 126 | 4 | CID000009649 | |
| Drug | Dixan | 4.10e-05 | 35 | 126 | 4 | CID000010404 | |
| Drug | Glutathione | 4.59e-05 | 36 | 126 | 4 | DB00143 | |
| Drug | Gsts | 5.12e-05 | 173 | 126 | 7 | CID000128079 | |
| Drug | CAS 87-33-2 | 5.33e-05 | 73 | 126 | 5 | CID000003780 | |
| Drug | Ethoxyquin | 7.00e-05 | 40 | 126 | 4 | ctd:D005015 | |
| Drug | monomethyl phthalate | FLT1 KRT10 CTSC CP RPSA INO80 GSTA1 NCOR2 IGF2R ABCB9 ASPM COPS4 ELK1 MMP1 RPA1 DNASE1L3 | 7.85e-05 | 957 | 126 | 16 | ctd:C517284 |
| Drug | zinc chloride (ZnCl2 | 8.08e-05 | 186 | 126 | 7 | CID000005727 | |
| Drug | Thiazoles | 8.79e-05 | 16 | 126 | 3 | ctd:D013844 | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 1.09e-04 | 195 | 126 | 7 | 166_UP | |
| Drug | copper(II) sulfate pentahydrate; Up 200; 100uM; ssMCF7; HG-U133A | 1.19e-04 | 198 | 126 | 7 | 500_UP | |
| Drug | 4-hydroxyanisole | 1.22e-04 | 46 | 126 | 4 | CID000009015 | |
| Drug | Isothiocyanates | 1.27e-04 | 18 | 126 | 3 | ctd:D017879 | |
| Drug | C14802 | 1.33e-04 | 47 | 126 | 4 | CID011954053 | |
| Drug | C14800 | 1.44e-04 | 48 | 126 | 4 | CID011954051 | |
| Drug | bromobenzene-3,4-oxide | 1.56e-04 | 49 | 126 | 4 | CID000108121 | |
| Drug | cobalt(II) chloride | 1.64e-04 | 146 | 126 | 6 | CID000024288 | |
| Drug | Chlorambucil | 1.69e-04 | 50 | 126 | 4 | ctd:D002699 | |
| Drug | phenanthroline | 1.69e-04 | 50 | 126 | 4 | CID000067473 | |
| Drug | bromobenzene-2,3-oxide | 1.69e-04 | 50 | 126 | 4 | CID003036760 | |
| Drug | 1,1-dichloroethylene epoxide | 1.69e-04 | 50 | 126 | 4 | CID000119521 | |
| Drug | CID5475388 | 1.76e-04 | 20 | 126 | 3 | CID005475388 | |
| Drug | 5-S-glutathionyl-alpha-methyldopa | 1.81e-04 | 4 | 126 | 2 | ctd:C086396 | |
| Drug | 5-S-glutathionyldopamine | 1.81e-04 | 4 | 126 | 2 | ctd:C086394 | |
| Drug | naphthalene epoxide | 1.83e-04 | 51 | 126 | 4 | CID000108063 | |
| Drug | dichloroacetaldehyde | 2.28e-04 | 54 | 126 | 4 | CID000006576 | |
| Drug | HBGG | 2.36e-04 | 22 | 126 | 3 | CID000125044 | |
| Drug | phenobarbital quinidine | 2.36e-04 | 22 | 126 | 3 | ctd:C033457 | |
| Drug | chloroacetyl chloride | 2.45e-04 | 55 | 126 | 4 | CID000006577 | |
| Drug | S-hexylglutathione | 2.45e-04 | 55 | 126 | 4 | CID000005140 | |
| Drug | Uranium | 2.48e-04 | 296 | 126 | 8 | ctd:D014501 | |
| Drug | oltipraz | 2.63e-04 | 56 | 126 | 4 | ctd:C026209 | |
| Drug | cyclohexanone | 2.82e-04 | 57 | 126 | 4 | CID000007967 | |
| Drug | tiadenol | 2.82e-04 | 57 | 126 | 4 | CID000023403 | |
| Drug | prostaglandin A2 | 3.01e-04 | 5 | 126 | 2 | ctd:C100008 | |
| Drug | 2-S-glutathionylcaffeic acid | 3.01e-04 | 5 | 126 | 2 | ctd:C082398 | |
| Drug | Gonadotropins | 3.01e-04 | 5 | 126 | 2 | ctd:D006062 | |
| Drug | Glycolates | 3.01e-04 | 5 | 126 | 2 | ctd:D006016 | |
| Drug | perhexiline | 3.01e-04 | 58 | 126 | 4 | CID000004746 | |
| Drug | bromoacetaldehyde | 3.01e-04 | 58 | 126 | 4 | CID000105131 | |
| Drug | beta-damascenone | 3.08e-04 | 24 | 126 | 3 | ctd:C075388 | |
| Disease | corneal neovascularization (implicated_via_orthology) | 1.75e-05 | 2 | 124 | 2 | DOID:11382 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | RC3H1 BACH2 SIM1 DOCK5 PTPRG CTNNA2 SCFD1 CAPS2 SKAP2 USH2A EPHB1 | 6.30e-05 | 619 | 124 | 11 | EFO_0003923, EFO_0004531 |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 1.74e-04 | 5 | 124 | 2 | OBA_2042200 | |
| Disease | level of prosaposin in blood serum | 1.74e-04 | 5 | 124 | 2 | OBA_2044552 | |
| Disease | non-alcoholic fatty liver disease severity measurement | 2.20e-04 | 28 | 124 | 3 | EFO_0008421 | |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 2.60e-04 | 6 | 124 | 2 | DOID:12716 (biomarker_via_orthology) | |
| Disease | Prostatic Neoplasms | SAMD9 TNFSF10 USP28 ANXA3 NDST4 GSTA1 SERPINB10 IGF2R PTPRC FBXO44 | 2.83e-04 | 616 | 124 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | SAMD9 TNFSF10 USP28 ANXA3 NDST4 GSTA1 SERPINB10 IGF2R PTPRC FBXO44 | 2.83e-04 | 616 | 124 | 10 | C0376358 |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 3.63e-04 | 7 | 124 | 2 | DOID:12716 (is_implicated_in) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 4.82e-04 | 8 | 124 | 2 | EFO_0801768 | |
| Disease | Psychotic Disorders | 8.86e-04 | 101 | 124 | 4 | C0033975 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.12e-03 | 12 | 124 | 2 | EFO_0801493 | |
| Disease | Oligospermia | 1.12e-03 | 12 | 124 | 2 | C0028960 | |
| Disease | granulins measurement | 1.12e-03 | 12 | 124 | 2 | EFO_0008141 | |
| Disease | abdominal aortic aneurysm (is_implicated_in) | 1.12e-03 | 12 | 124 | 2 | DOID:7693 (is_implicated_in) | |
| Disease | interleukin-6 measurement | 1.30e-03 | 112 | 124 | 4 | EFO_0004810 | |
| Disease | bronchopulmonary dysplasia (is_implicated_in) | 1.33e-03 | 13 | 124 | 2 | DOID:11650 (is_implicated_in) | |
| Disease | RAC-beta serine/threonine-protein kinase measurement | 1.33e-03 | 13 | 124 | 2 | EFO_0021989 | |
| Disease | Hamman-Rich syndrome | 1.54e-03 | 14 | 124 | 2 | C0085786 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 1.54e-03 | 14 | 124 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | 1,3,7-trimethylurate measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0021172 | |
| Disease | Libman-Sacks Disease | 1.89e-03 | 58 | 124 | 3 | C0242380 | |
| Disease | Keratoderma, Palmoplantar | 2.02e-03 | 16 | 124 | 2 | C4551675 | |
| Disease | Pre-Eclampsia | 2.02e-03 | 16 | 124 | 2 | C0032914 | |
| Disease | fourth ventricle volume measurement | 2.02e-03 | 16 | 124 | 2 | EFO_0010303 | |
| Disease | Nonorganic psychosis | 3.10e-03 | 69 | 124 | 3 | C0349204 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.17e-03 | 20 | 124 | 2 | C4721952 | |
| Disease | Lupus Erythematosus, Systemic | 3.36e-03 | 71 | 124 | 3 | C0024141 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.49e-03 | 21 | 124 | 2 | C1800706 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.92e-03 | 75 | 124 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | frailty measurement | 4.18e-03 | 23 | 124 | 2 | EFO_0009885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVDGYNKAKAYIATQ | 911 | P23470 | |
| ITYYEAALKTGQKNY | 776 | Q7Z4L5 | |
| YCDGIVKATTKIKYY | 266 | Q8NDB2 | |
| SAAGYNVKCAYKKYL | 376 | Q4LE39 | |
| KYQTVEKLQQYYIFI | 231 | Q9H0S4 | |
| KKLKYYTGNYDQYVK | 301 | Q9UG63 | |
| SKYVKLNVGGALYYT | 31 | Q9H3F6 | |
| YKKYQLACTKNVYNA | 231 | Q9BYV9 | |
| YYYDKNIIRKVSGQK | 66 | P19419 | |
| KKYVTLCSNGVLTYY | 141 | Q8TF27 | |
| YNKSVENYTDEKAKY | 441 | Q96G01 | |
| YQQCKTEIKEGYKQY | 136 | Q9BXY5 | |
| VKYYALKLEQESKAY | 126 | A6NNP5 | |
| KIYNYLDKYVVGQSF | 171 | O76031 | |
| QTYEEGLFYAQKSKK | 46 | Q8TD06 | |
| KKYQAIASNSKIYFG | 286 | O75477 | |
| KDISQAYYTVYKKSL | 126 | P12429 | |
| EKLKYLLLTYYDANK | 46 | A6QL64 | |
| KLYQSIIGYYAIDVK | 976 | Q9NSV4 | |
| KESILTIQKYYKAYL | 1511 | Q8IZT6 | |
| YKAYLKGKIERTNYL | 1521 | Q8IZT6 | |
| LKVAGKYKGNDYSQY | 796 | Q5TC82 | |
| KKNLQYYDISAKSNY | 141 | P62826 | |
| VYLVSGKNVGYAKYA | 421 | Q8IUH3 | |
| LLTKTYVLKSKLAYY | 301 | Q9ULW6 | |
| DIVTKVENYYLKGYI | 61 | Q52LD8 | |
| YYNLTKFYGTVKLDT | 541 | P25092 | |
| ILNYIASKYNLYGKD | 71 | P08263 | |
| ILNYIASKYNLYGKD | 71 | Q7RTV2 | |
| QYKLDGKIVNYYSKT | 451 | Q9H8X2 | |
| EKTYGNYYKLITSRV | 396 | Q9Y5H2 | |
| KDKELQQYQYYSAGL | 176 | Q9ULG1 | |
| GSKYKKVVYRQYTDS | 776 | P00450 | |
| KYIQKQISYNYSDLD | 236 | Q8NC51 | |
| NLYYYETDSVIATKK | 111 | P54762 | |
| KTVAECVLYYYLTKK | 461 | Q9Y618 | |
| YSKYYKTIDDLKNQI | 196 | P13645 | |
| YNLLSYKYLKKQSRE | 781 | Q8IX03 | |
| ILQKTGQEKIYYVGY | 171 | Q5VYY2 | |
| YLKEVDKNNKLYLSY | 301 | Q9Y231 | |
| TQYDGYAKTDLTIKY | 676 | Q5U5R9 | |
| FLKKIQDYQQFYGKS | 516 | Q5H9U9 | |
| ILNYIASKYNLYGKD | 71 | P09210 | |
| ILNYIASKYNLYGKD | 71 | Q16772 | |
| KVKDKVQYECATGYY | 171 | P05160 | |
| SKIYYNGDKVTYACK | 351 | P05160 | |
| LYKYINKYYDQIITA | 2091 | O43157 | |
| NNSKNYSLKYTKYTK | 271 | P35663 | |
| KSTYGNGKKYIATAY | 391 | P21128 | |
| QKQYNVDYKLETYLK | 136 | Q9BT78 | |
| QVKKYFVTSYYTCLK | 121 | Q9H4M3 | |
| VYNVTYTVKEKGDYI | 2691 | Q14315 | |
| ETQNGYYVKSYKLEV | 351 | O60462 | |
| YYVKSYKLEVSTNGE | 356 | O60462 | |
| ELTKYKIVTYLGLYN | 751 | Q9Y239 | |
| GKYTLVIYENILKYV | 126 | Q9H3R1 | |
| KVTYTVQYFIYGQKK | 66 | Q9UHF4 | |
| YLKQGKYQDAETLYK | 376 | Q9H0B6 | |
| VNKVYYFSKGTLKIA | 251 | P27694 | |
| KESYSIYIYKVLKQV | 36 | Q96A08 | |
| YYNKYINVKKGSISG | 51 | P56134 | |
| KVVSYENINKNDYYT | 221 | Q9C0G6 | |
| NTYKEQYAFLYKEKL | 96 | Q13609 | |
| EGISEYKSVVYYQVK | 491 | Q9H7D0 | |
| KASYVASTKYQKVYG | 881 | P26232 | |
| YKNGTYYDCIKSKAR | 51 | Q075Z2 | |
| VVYYVNKDFKNEYKG | 296 | Q8TBM8 | |
| IVSKYDPNVYSIKYN | 221 | P06756 | |
| LKNSQEKYSNRLYKY | 156 | P53634 | |
| QCVEFYYTYKKQVKI | 866 | Q6PJG2 | |
| YYTYKKQVKIGRNGT | 871 | Q6PJG2 | |
| YTENLVAYTSYEKNK | 626 | Q5T6L9 | |
| EKNGNYYKDIKQYVF | 56 | Q9NQ60 | |
| VGRNYYTKKKAIQLY | 241 | Q7Z3Z3 | |
| SYLYEKLYQKQIDSN | 111 | Q6YP21 | |
| SLYFNKYQSNIIIKY | 301 | Q96PB7 | |
| YASYKAVKTKNIREY | 21 | Q9H6H4 | |
| LCLYQLVKTYEYKKA | 151 | O15397 | |
| GVSYYINLCQKIYKG | 2021 | P11717 | |
| QYIYKRKSDGIYIIN | 36 | P08865 | |
| YDIRIQKIGSNYKAY | 291 | O14994 | |
| TEYSIYVNNKLYKTG | 3051 | O75445 | |
| DYKVYGYVTNSKVKF | 66 | Q9UL33 | |
| KYLEKYYNLKNDGRQ | 36 | P03956 | |
| KTVFYYYGSDKDKQQ | 146 | O75563 | |
| TFLEYYSKNYGITVK | 451 | Q8TC59 | |
| QYSIQTAIAKKYIRY | 811 | Q5K651 | |
| QYKFYSVNVDYSKLK | 61 | O00483 | |
| LPSNQKTYYDSIKKY | 551 | Q7Z3Z4 | |
| QSISKALVAYYQKYV | 86 | P62249 | |
| VKGQVTTKYYRFLAK | 286 | P81133 | |
| VYYKAKSEGTYLNSV | 1011 | P41252 | |
| SGVYIYYTKLQGKSL | 861 | Q6UXD5 | |
| SFVKKYNTYAYVGLT | 176 | Q8IWL1 | |
| IKAQGYKVFSKFYLT | 221 | Q9BQ13 | |
| CQYKEVLKQYQLKYS | 116 | Q8N1H7 | |
| SFVKKYNTYAYVGLT | 176 | Q8IWL2 | |
| YGKYYKRLSKEVQNA | 346 | Q9NP78 | |
| EKIANYKEGTYVYKT | 166 | P58418 | |
| ALQAYESYKKKDYTQ | 421 | Q96F05 | |
| ESYKKKDYTQVDYLI | 426 | Q96F05 | |
| KYKYQVNVDGTVAAY | 366 | Q7Z4H8 | |
| ATLNTKEGYSYLYIK | 86 | A0A0B4J272 | |
| EYKQKIKEYIQKYAT | 136 | P62256 | |
| LGCKKFYYSKIEYQN | 806 | Q13129 | |
| GQYDIVQKKTSYYEN | 161 | Q8N412 | |
| EKYQQYKDIYTALKK | 576 | Q08AE8 | |
| DVAYQYVKKGSRIYL | 96 | Q04837 | |
| LKKYNVEYQEYLQSK | 126 | Q96FJ0 | |
| VEYQEYLQSKNKYKA | 131 | Q96FJ0 | |
| VENFYKYVSKYSLVK | 16 | Q96FQ6 | |
| QYGKAYVDYKTVLQI | 536 | Q07617 | |
| EFVKYYKQLQKEYIS | 391 | Q8IWV7 | |
| IYKYGKLSKLAETLY | 2011 | Q6N022 | |
| YIEYQNLVDYIKGKQ | 601 | Q8WVM8 | |
| FLIKYKPLKYNNIYT | 531 | P48066 | |
| YLLTGLELYQKGKYQ | 901 | Q96RU2 | |
| LELYQKGKYQEALSY | 906 | Q96RU2 | |
| GVRYNAEKKKVGNYY | 66 | P13994 | |
| YYYVNIEKTEKNKNK | 421 | Q5GH77 | |
| FVKYYYSGKREKVLN | 211 | Q9UPP1 | |
| PYYYKKKNTFIVLNK | 71 | Q01118 | |
| YLKYINLKASEKLDY | 146 | Q12874 | |
| ISYYSKYKNAGVIEL | 331 | Q96Q05 | |
| KKQTTYQSDYDKTYP | 231 | Q8N6G2 | |
| KNDKQMVQYIYKYTS | 201 | P50591 | |
| YCKYGNLSNYLKSKR | 911 | P17948 | |
| KYANITVDYLYNKET | 231 | P08575 | |
| YLLKTANAIYGEKTY | 106 | P48595 | |
| YLKGQVKFKSSNYVL | 331 | Q96FV9 | |
| SKVKAQLYAQAYDLY | 611 | Q9NX78 | |
| KLSQEINYAKSLYYE | 4356 | Q5THJ4 | |
| SDIDKYYTEQKKQEY | 421 | A6PVS8 | |
| KKTFYYLEQLILKYG | 166 | Q96D46 | |
| DIASDYKYKQGYRKQ | 2301 | P20929 | |
| VISDYKYKDGYRKQL | 3031 | P20929 |